Parametrica Management LTD Abb Vie Inc. Transaction History

Parametrica Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $221,991 - $299,711	-2,758 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $236,939 - $278,089	2,758 New	2,758 $241,000
Q2 2018 Jul 23, 2018	SELL	$89.78 - $106.23 $461,199 - $545,703	-5,137 Closed	0 $0
Q1 2018 Apr 24, 2018	BUY	$92.01 - $123.21 $204,262 - $273,526	2,220 Added 76.11%	5,137 $486,000
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $547,838 - $600,750	-6,117 Reduced 67.71%	2,917 $282,000
Q3 2017 Oct 27, 2017	BUY	$69.85 - $89.22 $631,024 - $806,013	9,034	9,034 $803,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.